Results 221 to 230 of about 25,747,115 (388)

Big data, data science, and big contributions [PDF]

Nursing Outlook, 2016
openaire   +2 more sources

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Big data in modelling geographical accessibility to healthcare: a scoping review protocol. [PDF]

BMJ Open
Njogu A, Libertini L, Avahoundjè EM, Grovogui FM, Ba OA, Ray N, Beňová L, Macharia PM.   +7 more
europepmc   +1 more source

Emergent Technologies in Big Data Sensing: A Survey

, 2015
Ting Zhu, Sheng Xiao, Qingquan Zhang, Yu Gu, Ping Yi, Yanhua Li   +5 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Adaptive federated clustering for uncertainty-aware learning on decentralized big data platforms. [PDF]

PLoS One
Alhazmi MH.
europepmc   +1 more source

Research on the Innovation of Physical Education and Physical Education Teaching Based on Big Data Analysis

, 2023
Mingyi Sun, Zhiyong Gu
openalex   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Training path of big data management and application talents based on BERTopic-TOPSIS model. [PDF]

PLoS One
Li Y, Huang T, Li X.
europepmc   +1 more source

Scalable and flexible management of medical image big data

, 2018
Dejun Teng, Jun Kong, Fusheng Wang
openalex   +2 more sources